Company Comparison
Tessera Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tessera Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | Lagos, Nigeria |
| Founded | 2018 | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series B | Series B |
| Total Funding | $300M | $45M |
| Valuation | — | — |
What They Build
Tessera Therapeutics
Gene writing company developing a new class of genetic medicines that can write therapeutic messages into the genome to treat or cure diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Tessera Therapeutics
Sector Overlap
Both Tessera Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →